Skip to main content

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

July 2016 - FRMC

Department
07/14/2016
New policy adopted by the American Medical Association (AMA) at its annual meeting in Chicago, IL (June 11-15, 2016) calls for equal health care access and payment for eating disorders.
New policy adopted by the American Medical Association (AMA) at its annual meeting in Chicago, IL (June 11-15, 2016) calls for equal health care access and payment for eating disorders.
New policy adopted by the...
07/14/2016
First Report Managed Care
Department
07/14/2016
The American Medical Association (AMA) is calling for public and private health insurers to include the Centers for Disease Control and Prevention (CDC)’s National Diabetes Prevention Program as a covered benefit for beneficiaries at risk of...
The American Medical Association (AMA) is calling for public and private health insurers to include the Centers for Disease Control and Prevention (CDC)’s National Diabetes Prevention Program as a covered benefit for beneficiaries at risk of...
The American Medical Association...
07/14/2016
First Report Managed Care
Department
07/14/2016
What the Value Framework is intended to do is take elements of care doctors already view as being important—clinical benefit, toxicity, cost—and make them part of the discussion at the point of care for patients. This is especially important...
What the Value Framework is intended to do is take elements of care doctors already view as being important—clinical benefit, toxicity, cost—and make them part of the discussion at the point of care for patients. This is especially important...
What the Value Framework is...
07/14/2016
First Report Managed Care
Department
07/14/2016
One year after implementation, a value-based health care (VBHC) program for patients with inflammatory bowel disease (IBD) showed less use of steroids, imaging studies, emergency room visits and hospitalizations, and increased biomarker...
One year after implementation, a value-based health care (VBHC) program for patients with inflammatory bowel disease (IBD) showed less use of steroids, imaging studies, emergency room visits and hospitalizations, and increased biomarker...
One year after implementation, a...
07/14/2016
First Report Managed Care
Department
07/14/2016
Addressing the psychosocial needs of patients with inflammatory bowel disease may improve medical and psychosocial outcomes.
Addressing the psychosocial needs of patients with inflammatory bowel disease may improve medical and psychosocial outcomes.
Addressing the psychosocial...
07/14/2016
First Report Managed Care
Department
07/14/2016
New data from the IRIS trial showed that pioglitazone reduced the likelihood of progression to diabetes in those with insulin resistance and cerebrovascular disease.
New data from the IRIS trial showed that pioglitazone reduced the likelihood of progression to diabetes in those with insulin resistance and cerebrovascular disease.
New data from the IRIS trial...
07/14/2016
First Report Managed Care
Department
07/14/2016
African Americans with type 2 diabetes experience increased morbidity and mortality. Prior diabetes self-management programs have failed to demonstrate long-term efficacy in this population.
African Americans with type 2 diabetes experience increased morbidity and mortality. Prior diabetes self-management programs have failed to demonstrate long-term efficacy in this population.
African Americans with type 2...
07/14/2016
First Report Managed Care
Department
07/14/2016
Health-related quality of life (HRQOL) is an important area of investigation that continues to gain recognition and is a critical element of diabetes research, treatment, and care, according to a panel of experts who discussed this topic...
Health-related quality of life (HRQOL) is an important area of investigation that continues to gain recognition and is a critical element of diabetes research, treatment, and care, according to a panel of experts who discussed this topic...
Health-related quality of life...
07/14/2016
First Report Managed Care
Department
07/14/2016
Data from the LEADER (Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results-A Long Term Evaluation) trial showed a reduction in major cardiovascular events with the glucose-lowering drug liraglutide (Victoza;...
Data from the LEADER (Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results-A Long Term Evaluation) trial showed a reduction in major cardiovascular events with the glucose-lowering drug liraglutide (Victoza;...
Data from the LEADER...
07/14/2016
First Report Managed Care

Advertisement

Advertisement

Advertisement